Language: English
Current: English
- English
- 中文
- 日本語
- Español
Region: Americas
Current Americas

Become a member
Cart (0)
Sign in

Already a DIA Member? Sign in. Not a member? Join.

Keep me logged in

Forgot User ID? or Forgot Password?

Create Account and Join Register

Menu Back toAgenda

Biosimilars Conference

Agenda

Day 1 Oct 05, 2020

12:00 PM — 3:30 PM Short Course: Current Biosimilar Policies: An Interactive Boot Camp for US Market Success

Day 2 Oct 06, 2020

10:00 AM — 10:40 AM Welcome, Opening Remarks, and Keynote Address
10:40 AM — 10:55 AM Break
10:55 AM — 12:10 PM Session 2: Biosimilars During a Pandemic
12:10 PM — 12:40 PM Break
12:40 PM — 1:55 PM Session 3: Streamlining Biosimilar Clinical Development
1:55 PM — 2:20 PM Break
2:20 PM — 3:35 PM Session 4: A Success of Our Own: How Do We Define the U.S.’ Biosimilar Success Story?
3:35 PM — 4:05 PM Break
4:05 PM — 5:20 PM Session 5: What Will Biosimilars Look Like in Five Years?
5:30 PM — 6:15 PM Reception Round Tables – How Can We Communicate New Data Methods to Build Public and Healthcare Provider Confidence in Biosimilars?
5:30 PM — 6:15 PM Reception Round Tables - Interchangeability: Value and Outstanding Unknowns
5:30 PM — 6:15 PM Reception Round Tables – Market Challenges for Biosimilars
5:30 PM — 6:15 PM Reception Round Tables - To Help Optimize Biosimilar Competitiveness in the Market, What Can Developers of Biosimilars do to Streamline Development and Manufacturing to Lower Development Costs and the Cost of Goods?

Day 3 Oct 07, 2020

10:00 AM — 11:15 AM Session 6: Growing Clinical Use and Experience: What Can be Learned From Key International Initiatives?
11:25 AM — 12:40 PM Session 7: Prescriber and Patient Confidence with Biosimilar Use
12:40 PM — 1:10 PM Break
1:10 PM — 2:40 PM Session 8: Stakeholder Voice: Biosimilar Decision Making
2:40 PM — 3:00 PM Break
3:00 PM — 4:30 PM Session 9: Regulatory Landscape – Ask the Regulators and Closing Remarks
4:40 PM — 5:25 PM Reception Round Tables - How Can We Communicate New Data Methods to Build Public and Healthcare Provider Confidence in Biosimilars?
4:40 PM — 5:25 PM Reception Round Tables - Interchangeability: Value and Outstanding Unknowns
4:40 PM — 5:25 PM Reception Round Tables - Market Challenges for Biosimilars
4:40 PM — 5:25 PM Reception Round Tables - To Help Optimize Biosimilar Competitiveness in the Market, What Can Developers of Biosimilars do to Streamline Development and Manufacturing to Lower Development Costs and the Cost of Goods?
5:25 PM — 5:25 PM Conference Adjourns

Contact us

Registration Questions?

Send Email
1.888.257.6457

Preconference Short Courses

Short Course 1: Current Biosimilar Policies: An Interactive Boot Camp for US Market Success